Download full-text PDF

Source
http://dx.doi.org/10.1111/all.15892DOI Listing

Publication Analysis

Top Keywords

hypoallergenic chimeric
4
chimeric virus-like
4
virus-like particles
4
particles development
4
development shrimp
4
shrimp tropomyosin
4
tropomyosin allergen
4
allergen pen
4
pen 1-specific
4
1-specific blocking
4

Similar Publications

Novel allergen immunotherapy (AIT) approaches necessitate the use of more effective and safe therapeutics, which can be accomplished by employing novel adjuvants for improved innate immune cell activation, as well as hypoallergenic allergen forms. In this study, we investigate the immunomodulatory effects of a chimera rBet v 1a-BanLec (rBv1a-BL; C) composed of the major birch pollen allergen Bet v 1a and banana lectin (BanLec; BLwt) and two novel chimeras, rBv1l-BL (rBet v 1l-BanLec; C1) and rBL-Bv1l (rBanLec-Bet v 1l; C2), both composed of BL and hypoallergenic birch pollen allergen Bv1l in the co-culture model Caco-2/THP-1, and PBMCs from donors with birch pollen allergy. The chimeric molecules rBv1l-BL (C1) and rBL-Bv1l (C2) were created in silico and then produced in E.

View Article and Find Full Text PDF

Introduction: Hypoallergenic formulas prepared from hydrolyzed cow's milk proteins are often used for the management of cow's milk allergy (CMA) in infants. In this study, both in vitro assays and an in vivo mouse model for CMA were used to assess the sensitizing and allergenic potential of a newly developed, extensive whey hydrolysate (eWH).

Methods: Gel permeation chromatography was used to characterize the molecular weight distribution of the peptides.

View Article and Find Full Text PDF

We investigated the prophylactic and therapeutic effects of the oral administration of transgenic rice seeds expressing a hypoallergenic Bet v 1 derivative of allergic birch pollen conjunctivitis in mice. Transgenic rice seed depositing a chimeric molecule called TPC7 (tree pollen chimera 7) created by DNA shuffling of Bet v 1 family sequences from birch, alder and hazel in protein bodies of endosperm was generated. BALB/c mice were sensitized to birch pollen in alum and challenged with pollen in eyedrops.

View Article and Find Full Text PDF

Specific immunotherapy (SIT) is the only treatment that provides long lasting relief of allergy symptoms. Unfortunately, SIT-based traditional remedies carry the risk of producing local and/or systemic side effects. To improve the safety and efficacy of SIT, it has been proposed that SIT must utilize allergens that are hypoallergenic but hyperimmunogenic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!